Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of activetuberculosis, latent infection and cured disease.
S. Díaz Fernández (Barcelona, Spain), R. Villar-Hernández (Barcelona, Spain), Z. Stojanovic (Barcelona, Spain), M. Fernández-Sanmartín (Barcelona, Spain), M. De Souza-Galvão (Barcelona, Spain), G. Tolosa (Temuco, Chile), A. Sánchez-Montalva (Barcelona, Spain), J. Abad (Barcelona, Spain), M. Jiménez-Fuentes (Barcelona, Spain), G. Safont (Barcelona, Spain), I. Romero (Barcelona, Spain), J. Sabrià (Barcelona, Spain), C. Prat (Barcelona, Spain), J. Domínguez (Barcelona, Spain), I. Latorre (Barcelona, Spain)
Source: International Congress 2022 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and NTM
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Díaz Fernández (Barcelona, Spain), R. Villar-Hernández (Barcelona, Spain), Z. Stojanovic (Barcelona, Spain), M. Fernández-Sanmartín (Barcelona, Spain), M. De Souza-Galvão (Barcelona, Spain), G. Tolosa (Temuco, Chile), A. Sánchez-Montalva (Barcelona, Spain), J. Abad (Barcelona, Spain), M. Jiménez-Fuentes (Barcelona, Spain), G. Safont (Barcelona, Spain), I. Romero (Barcelona, Spain), J. Sabrià (Barcelona, Spain), C. Prat (Barcelona, Spain), J. Domínguez (Barcelona, Spain), I. Latorre (Barcelona, Spain). Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of activetuberculosis, latent infection and cured disease.. 4092
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|